Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

29 Oct 2020 07:00

RNS Number : 5345D
Biome Technologies PLC
29 October 2020
 

29 October 2020

Biome Technologies plc

("Biome", the "Group" or the "Company")

Trading Update

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides a trading update for the nine months ended 30 September 2020.

 

Bioplastics Division

 

Revenues in the Bioplastics division in Q3 at £1.6m were 48% ahead of the previous quarter (Q2 2020: £1.1m) and 131% ahead of the prior year comparative (Q3 2019: £0.7m).

 

The division's revenues in the first nine months of the financial year stood at £3.8m, 93% ahead of the equivalent period last year (2019: £2.0m).

 

Revenues in Q3 reflected strong underlying demand for products that have been commercialised for some time (e.g. outer packaging and non-woven filter mesh applications for the US coffee market), coupled with growing revenues in rigid materials used in coffee pods. The Board expects revenues in Q4 to be below the Q3 quarterly level but in line with its expectations for this financial year.

 

The Bioplastics division is working with an expanding list of potential new customers, particularly in the US. Developmental work related to this continues with some vigour, despite the impact of Covid-19. In particular, the implementation of a filtration mesh project with a second US end-customer has moved forward assuredly and initial revenues are expected later this quarter.

 

During Q3, the activities of the Bioplastics division were recognised when Biome received the London Stock Exchange's Green Economy Mark. The Green Economy Mark, launched in 2019, recognises listed companies and funds which derive 50% or more of their revenues from environmental solutions.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in Q3 were £0.2m (Q3 2019: £0.6m), resulting in revenues in the first nine months of the financial year of £0.6m (2019: £2.8m).

 

The fibre optic cable market, normally a major driver of the business, remains impacted by both over-capacity and COVID-19 disruption. The division continues to make a concerted effort to increase its geographic footprint and range of applications and already benefits from recurring revenue from power generation, medical and general industrial markets.

The business has continued to win small projects in the UK induction heating and welding market, but overall demand remains subdued.

 

 

Group Performance

 

Total Group revenues in Q3 were £1.8m (2019: £1.3m) taking Group revenues for the nine months to 30 September 2020 to £4.3m (2019: £4.7m). It is to be noted that all revenue figures in this statement exclude grant income (£38,000 in the third quarter of this year and £124,000 for the nine months).

 

Costs and capital expenditure continue to be managed tightly and as the Government furlough scheme ends in October, activity levels are such that staff are returning to normal duties.

 

The Group's cash position as at 30 September 2020 was £0.9m (30 June 2020: £1.1m) and the Group had no debt.

 

 

In September 2020, the Group announced that it had raised £1.1m (£1.0m net of costs), via a fundraising made up of three tranches, to support and accelerate the Bioplastics division's growth. Shareholder approval was obtained on 12 October 2020 and the net proceeds from the first and second tranches have now been received which enhances the Group's cash position from that at the end of Q3.

 

Group Outlook

 

The funds from the recent fundraise will support a vigorous approach to growing the Group's bioplastics business. It is against the above that the Board expects the full year results to be in line with current market expectations.

 

Ends-

 

For further information please contact: Biome Technologies plc

Paul Mines, Chief Executive Officer

Donna Simpson-Strange, Company Secretary

info@biometechnologiesplc.co.uk

Tel: +44 (0) 2380 867 100

www.biometechnologiesplc.com

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Equity Sales)

Tel: +44 (0) 20 3328 5656

www.allenbycapital.com

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where value-added pricing can be justified and which are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKFBNCBDDKKB
Date   Source Headline
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSContract
17th Mar 20217:00 amRNSUpdate on biodegradable tree shelter project
16th Mar 20217:00 amRNSBiome commits to UN Race to Zero climate campaign
28th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSUpdate on biodegradable tree shelter project
31st Dec 20201:30 pmRNSTotal Voting Rights
15th Dec 20207:00 amRNSBiome's RF division gains traction
11th Dec 20208:05 amRNSAdmission of Subscription Shares
6th Nov 20204:41 pmRNSSecond Price Monitoring Extn
6th Nov 20204:35 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSBiome starts biodegradable tree shelter project
30th Oct 20205:00 pmRNSTotal Voting Rights
30th Oct 20207:00 amRNSDirector/PDMR Shareholding
29th Oct 20207:01 amRNSAppointment of Group Chief Financial Officer
29th Oct 20207:00 amRNSTrading Update
22nd Oct 202012:28 pmRNSHolding(s) in Company
19th Oct 20202:17 pmRNSHolding(s) in Company
12th Oct 20204:07 pmRNSResult of General Meeting
1st Oct 202010:55 amRNSHolding(s) in Company
24th Sep 20207:05 amRNSProposed Fundraise of £1.1 million & Notice of GM
24th Sep 20207:00 amRNSInterim Results
26th Aug 20207:00 amRNSGrant funding from Innovate UK
19th Aug 20207:00 amRNSOrder for compostable bioplastic for coffee pods
30th Jul 20207:00 amRNSTrading Update
25th Jun 20203:46 pmRNSResult of Annual General Meeting
2nd Jun 202010:35 amRNSNotice of Annual General Meeting 2020
22nd Apr 20207:00 amRNSTrading Update
20th Apr 20202:16 pmRNSAnnual Report and Accounts
16th Apr 20207:00 amRNSFinal Results 2019
25th Mar 20207:00 amRNSUpdate re Final Results, 2019 Annual Report & AGM
13th Feb 20204:01 pmRNSNotification of awards under the 2017 LTIP
30th Jan 20204:10 pmRNSShare option awards in lieu of historic bonuses
30th Jan 20207:00 amRNSTrading statement and Board change
4th Nov 20197:00 amRNSBiome to present at Mello London 2019
31st Oct 20195:30 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSTrading update
30th Sep 20193:04 pmRNSResult of General Meeting
12th Sep 20197:05 amRNSProposed Placing to raise £1.3 million
12th Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSTrading Update
25th Jun 20199:17 amRNSLong Term Incentive Plan Second Vesting
17th Jun 20194:12 pmRNSDirector/PDMR/PCA Shareholding
14th Jun 20197:00 amRNSBioplastics Product Update
24th Apr 20191:59 pmRNSResult of Annual General Meeting
24th Apr 20197:00 amRNSTrading Update
4th Apr 201912:20 pmRNSDirector/PDMR/PCA Shareholding
29th Mar 20199:22 amRNSNotice of AGM and Annual Report
28th Mar 20197:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.